T 0679/23 (anti-CLD18.2 combination therapy/ASTELLAS PHARMA) of 14.02.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T067923.20250214
- Date of decision
- 14 February 2025
- Case number
- T 0679/23
- Petition for review of
- -
- Application number
- 17171169.0
- IPC class
- A61K 45/06A61K 39/395C07K 16/30
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
- Applicant name
- Astellas Pharma Inc.
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH - Opponent name
- Dr. H. Ulrich Dörries
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.